Hypoglycemia in Diabetes: Does Insulin Type Matter?
Seaquist ER, Chow LS
JAMA. 2017 Jul 4;318(1):31-32.
Leggi
Breaking news
Human Insulin for Type 2 Diabetes.An Effective, Less-Expensive Option
Lipska KJ, Hirsch IB, Riddle MC
JAMA. 2017 Jul 4;318(1):23-24
Leggi
An Aggregate Biomarker Risk Score Predicts High Risk of Near‐Term Myocardial Infarction and Death: Findings From BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes)
Ghasemzadeh N, Brooks MM, Vlachos H, et al.
J Am Heart Assoc. Pub. online July 3, 2017.
Leggi
Effect of Insulin Degludec vs Insulin Glargine U100 on Hypoglycemia in Patients With Type 1 DiabetesThe SWITCH 1 Randomized Clinical Trial
Lane W, Bailey TS, Gerety G, et al.
JAMA. 2017 Jul 4;318(1):33-44.
Leggi
Targeting One-Hour Postmeal Glucose: Is It Time for a Paradigm Switch in Diabetes Management?
Ceriello A
Diabetes Technology & Therapeutics. Pub. Online June 30, 2017.
Leggi
Continuous Subcutaneous Insulin Infusion for Adults with Type 1 Diabetes Mellitus
Shamliyan TA, Lee CJ
The American Journal of Medicine. Pub. online 28 June 2017
Leggi
Effect of Insulin Degludec vs Insulin Glargine U100 on Hypoglycemia in Patients With Type 2 DiabetesThe SWITCH 2 Randomized Clinical Trial
Wysham C, Bhargava A, Chaykin L, et al.
JAMA. 2017 Jul 4;318(1):45-56.
Leggi
A practical framework for encouraging and supporting positive behaviour change in diabetes
Fisher L, Polonsky WH, Hessler D and Potter MB
Diabetic Medicine. Pub online 21 June 2017.
Leggi
Behavioural implications of traditional treatment and closed-loop automated insulin delivery systems in Type 1 diabetes: applying a cognitive restraint theory framework
Kahkoska AR, Mayer-Davis EJ, Hood KK, et al.
Diabetic Medicine. Pub online 19 June 2017.
Leggi
Risk of allergic conjunctivitis in patients with type 1 diabetes mellitus: a population-based retrospective cohort study
Chen Y-H, Lin C-L, Bau D-T and Hung Y-C
BMJ Open 2017;7:e015795.
Leggi